Stock price when the opinion was issued
Remains one of the most compelling automation platforms in the market. Benefits directly from structural shifts in reshoring, labour scarcity, and modernization of global manufacturing. Positioned at the high-value end of this trend.
Project pipeline remains healthy. Margins improving. Recent price momentum reflects business resilience. Sees ~10% upside, with strong price target around $49-50. No dividend.
(Note the short timeframe.) Not a full year, so letting the stock play out. Still builds the machines that build everything else, and they sit quietly behind the products we all rely on. Analysts have recently raised price targets. Revenue growth expected to cool, but profitability is doing more of the heavy lifting.
She sees ~25% upside from here. 8/10 on fundamentals. Should do well in next 6-12 months.
Upward trend from April selloff, showing strong support from the technical side. Fiscal 2025 EPS was slightly down, but forecast to rebound. Price target is 10% upside from here. Still below 52-week high. Analysts remain confident in company's leadership despite CEO stepping down, and she'll be monitoring closely.
Struggling. The best we can say is that the chart seems finally to be stabilizing. Hard to say whether it needs a washout before the downtrend is over. Trying to bottom, but hasn't picked up yet.
When you ask yourself what could happen, technicians look at a 50% retracement, where a stock would give up half of the move. So, if you went from $15 to $60, that's a $45 gain. Half of that is $22.50. The high of $60 - $22.50 brings you to $37.50, which is close to the 2022 lows.
Investors are still fretting about the decline in the backlog, and then its largest shareholder compounded problems by selling a large block of shares. We would remain a HOLD at the current (cheap) valuation and reference this recent answer. We might start picking away with more at the $42 level in any further declines.
Unlock Premium - Try 5i Free
Lots of contracts in last year that were EV-related. Recently, EV sales slowed. Market got worried, stock came down. Yesterday, largest shareholder offloaded stock. Good time to buy in mid-high $40s, EVs aren't going away. Probably just delays, no cancellations. Accretive acquisitions in life sciences, which are high margin.
Has sold shares in this business. Sold out at $55. Appears to be recovering. Will take time to tell future of business. Wait and see.